Divis Laboratories Ltd | DIVI - Gross Profit On Sales

Stock Price
6,017.00
Daily Change
-124.50 -2.03%
Monthly
-9.42%
Yearly
-2.01%
Q1 Forecast
5,937.24

Divis Laboratories Ltd reported INR14.54B in Gross Profit on Sales for its fiscal quarter ending in June of 2025.





Gross Profit On Sales Change Date
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Aurobindo Pharma INR 49.47B 3.18B Sep/2025
Avita Medical AUD 14.95M 1.18M Jun/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Divis Laboratories Ltd INR 14.54B 1.5B Jun/2025
Ionis Pharmaceuticals USD 155M 293M Sep/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Lupin INR 49.06B 7.09B Sep/2025
Moderna USD 809M 791M Sep/2025
Organon & Co USD 857M 17M Sep/2025
Revvity USD 374.6M 17.95M Sep/2025
Tectonic Therapeutic USD 0 0 Mar/2025
Tilray USD 67.63M 15.62M Mar/2025
Viatris USD 1.37B 38.6M Sep/2025
Xeris Pharmaceuticals USD 63.38M 3.74M Sep/2025